Oncothyreon

Clinical-stage biopharmaceutical company focusing on the development of therapeutic products for the treatment of cancer.

HQ location

Seattle, United States

Website

Launch date

1985

Employees

Recent deals

Get premium to view all results

Date	Investors	Amount	Round
Jan 1985	investor	€0.0	round
Nov 1991	N/A	€0.0	round
Sep 2010	investor investor investor investor investor investor investor	€0.0	round
Apr 2011	investor investor investor investor investor investor investor	€0.0	round
May 2013	Cowen Group Hudson Bay Capital Management Dafna Capital Management Ayer Capital Management Straus Partners Iroquois Capital Heights Capital Management	$10.0m	Post IPO Equity
Total Funding		000k